C4 Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:CCCC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -33.28 M-12.06 M-31.21 M-22.14 M-29.94 M -95.35 M Cash from investing activities 29.13 M38.92 M4.09 M-80.73 M16.15 M -21.57 M Cash from financing activities -46 K07.77 M118.67 M462 K 126.91 M Free cash flow -33.28 M-12.06 M-31.21 M-22.14 M-29.94 M -95.35 M

News

Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?

C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know

C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including Cemsidomide - Slideshow (NASDAQ:CCCC) 2026-06-20

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?

Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential (NASDAQ:GLUE)

C4 Therapeutics "Buy" On Cemsidomide Advancement And Competitor's Positive Readout (NASDAQ:CCCC)

C4 Therapeutics (CCCC) Upgraded to Buy: What Does It Mean for the Stock?

Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year?

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) Reports Q1 Loss, Beats Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates